SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Anderson Sarah Taylor

(Last) (First) (Middle)
6800 WEST 115TH STREET
SUITE 2511

(Street)
OVERLAND PARK KS 66211

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/09/2023
3. Issuer Name and Ticker or Trading Symbol
SelectQuote, Inc. [ SLQT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
(See Remarks)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share 8,614 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options(1) (2) 02/08/2028 Common Stock, par value $0.01 per share 17,000 $1.88 D
Employee Stock Options(1) (2) 08/20/2029 Common Stock, par value $0.01 per share 24,000 $3.13 D
Employee Stock Options(3) (4) 07/17/2030 Common Stock, par value $0.01 per share 20,000 $21.9 D
Employee Stock Options(3) (4) 08/01/2030 Common Stock, par value $0.01 per share 6,168 $17.89 D
Restricted Stock Units(5) (6) 08/01/2030 Common Stock, par value $0.01 per share 782 (7) D
Employee Stock Options(3) (4) 08/01/2031 Common Stock, par value $0.01 per share 10,712 $17.8 D
Restricted Stock Units(5) (6) 08/01/2031 Common Stock, par value $0.01 per share 2,718 (7) D
Employee Stock Options(3) (4) 03/10/2032 Common Stock, par value $0.01 per share 65,000 $2.51 D
Restricted Stock Units(5) (8) 08/01/2032 Common Stock, par value $0.01 per share 16,070 (7) D
Price-Vested Restricted Stock Units(9) (10) 08/01/2027 Common Stock, par value $0.01 per share 58,334 (11) D
Restricted Stock Units(5) (8) 08/01/2033 Common Stock, par value $0.01 per share 76,700 (7) D
Price-Vested Restricted Stock Units(9) (12) 08/01/2028 Common Stock, par value $0.01 per share 38,350 (11) D
Explanation of Responses:
1. Represents incentive stock options of SelectQuote, Inc. (the "Company") granted to the recipient pursuant to the Company's 2003 Stock Incentive Plan. Each option represents the contingent right to purchase one share of the Company's common stock, par value $0.01 per share, at a predetermined price specified in Column 4 of this table.
2. The option vests as to one-third on the first anniversary of the grant date and as to 1/24 of the remaining shares subject to the option monthly thereafter, subject to the recipient's continued employment with the Company through the applicable vesting date. As of the date hereof, the option has vested in full.
3. Represents non-qualified stock options of the Company granted to the recipient pursuant the the Company's 2020 Omnibus Incentive Plan (the "Plan"). Each option represents the contingent right to purchase one share of the Company's common stock, par value $0.01 per share, at a predetermined price specified in Column 4 of this table.
4. The option vests ratably in four annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.
5. Represents restricted stock units of the Company granted to the recipient pursuant to the Plan.
6. The restricted stock units vest ratably in four annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.
7. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock, par value $0.01 per share.
8. The restricted stock units vest ratably in three annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date.
9. Represents price-vested restricted stock units of the Company ("PVUs") granted to the recipient pursuant to the Plan.
10. The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $4.00, $7.50, $10.00, and $12.50 during the five-year performance period.
11. Each PVU represents the contingent right to receive one share of the Company's common stock, par value $0.01 per share, upon the Company's common stock reaching certain predetermined average trading prices, subject to applicable vesting conditions.
12. The PVUs are eligible to vest in three ratable annual installments commencing on the one-year anniversary of the grant date, subject to the recipient's continued employment with the Company through the applicable vesting date. Subject to this vesting schedule, one-fourth of the total number of PVUs granted will vest, if at all, upon the 60-day average closing price of the Company's common stock exceeding each of $2.50, $5.00, $7.50, and $10.00 during the five-year performance period.
Remarks:
Executive Vice President, Healthcare
/s/ Daniel A. Boulware, Attorney-in-Fact 08/18/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.